New medication may treat underlying causes of hypertrophic cardiomyopathy
The new, investigational heart medication mavacamten may improve key structural abnormalities of obstructive hypertrophic cardiomyopathy, a condition characterized by thickened heart muscle that obstructs pumping of blood ...
Nov 9, 2020
0
5